Hypertrophic cardiomyopathy (HCM) is the most common genetic
cardiovascular disease. Although some genes and
miRNAs related with HCM have been studied, the molecular regulatory mechanisms between
miRNAs and
transcription factors (TFs) in HCM have not been systematically elucidated. In this study, we proposed a novel method for identifying dysregulated
miRNA-TF feed-forward loops (FFLs) by integrating sample matched
miRNA and gene expression profiles and experimentally verified interactions of TF-target gene and
miRNA-target gene. We identified 316 dysregulated
miRNA-TF FFLs in HCM, which were confirmed to be closely related with HCM from various perspectives. Subpathway enrichment analysis demonstrated that the method was outperformed by the existing method. Furthermore, we systematically analysed the global architecture and feature of gene regulation by
miRNAs and TFs in HCM, and the FFL composed of hsa-miR-17-5p, FASN and STAT3 was inferred to play critical roles in HCM. Additionally, we identified two panels of
biomarkers defined by three TFs (CEBPB, HIF1A, and STAT3) and four
miRNAs (hsa-miR-155-5p, hsa-miR-17-5p, hsa-miR-20a-5p, and hsa-miR-181a-5p) in a discovery cohort of 126 samples, which could differentiate HCM patients from healthy controls with better performance. Our work provides HCM-related dysregulated
miRNA-TF FFLs for further experimental study, and provides candidate
biomarkers for HCM diagnosis and treatment.